血清标志物-话题@MedSci

#血清标志物#

27篇内容 | 1432人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1704078, encodeId=6ee71e0407863, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL, objectType=article, longId=221546, objectId=86b522154637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86b522154637, replyNumber=0, likeNumber=134, createdTime=2022-06-26, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86b522154637, moduleTitle=Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86b522154637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704077, encodeId=d1fe1e04077b1, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=Clin Trans Gastroenterology：β6 -整合素可作为胰腺腺癌诊断和预后的血清标志物, objectType=article, longId=215813, objectId=8bcd215813eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bcd215813eb, replyNumber=0, likeNumber=103, createdTime=2021-12-21, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bcd215813eb, moduleTitle=Clin Trans Gastroenterology：β6 -整合素可作为胰腺腺癌诊断和预后的血清标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bcd215813eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704076, encodeId=17d01e04076dc, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=2020脓毒症预防和阻断专家共识告诉你：这些血清标志物很重要！, objectType=article, longId=198770, objectId=3351198e7040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3351198e7040, replyNumber=0, likeNumber=92, createdTime=2020-11-03, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3351198e7040, moduleTitle=2020脓毒症预防和阻断专家共识告诉你：这些血清标志物很重要！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3351198e7040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704075, encodeId=c57d1e040757c, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=Gastric Cancer：血清标志物在胃癌及癌前病变中的作用, objectType=article, longId=176897, objectId=cd861e6897a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd861e6897a0, replyNumber=0, likeNumber=84, createdTime=2020-07-01, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd861e6897a0, moduleTitle=Gastric Cancer：血清标志物在胃癌及癌前病变中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd861e6897a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704073, encodeId=adfd1e0407341, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=PLOS ONE：肺癌患者的氧化应激与脂质代谢的血清标志物改变有关, objectType=article, longId=164253, objectId=706e16425344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=706e16425344, replyNumber=0, likeNumber=69, createdTime=2019-11-07, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=706e16425344, moduleTitle=PLOS ONE：肺癌患者的氧化应激与脂质代谢的血清标志物改变有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=706e16425344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704074, encodeId=62e61e040742e, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=Diabetes Care：氧化应激血清标志物与2型糖尿病患者的主要心血管事件、癌症发病率和全因死亡率的关联, objectType=article, longId=167742, objectId=89cb16e7425b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89cb16e7425b, replyNumber=0, likeNumber=59, createdTime=2020-04-01, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89cb16e7425b, moduleTitle=Diabetes Care：氧化应激血清标志物与2型糖尿病患者的主要心血管事件、癌症发病率和全因死亡率的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89cb16e7425b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704072, encodeId=13011e0407218, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=对话检验与临床：科学应用，合理解读 ——血清标志物优化甲状腺疾病临床诊疗, objectType=article, longId=154511, objectId=1d19154511b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d19154511b3, replyNumber=0, likeNumber=76, createdTime=2019-09-11, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d19154511b3, moduleTitle=对话检验与临床：科学应用，合理解读 ——血清标志物优化甲状腺疾病临床诊疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d19154511b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704071, encodeId=fe251e04071c0, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=J Clin Periodontol：唾液和血清标志物在牙周炎和冠心病中的应用, objectType=article, longId=148617, objectId=0bf914861e1a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bf914861e1a, replyNumber=0, likeNumber=80, createdTime=2019-01-05, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bf914861e1a, moduleTitle=J Clin Periodontol：唾液和血清标志物在牙周炎和冠心病中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bf914861e1a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704070, encodeId=9a671e0407052, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=临床肝胆病杂志：酒精性肝纤维化的血清标志物, objectType=article, longId=132809, objectId=a8d21328098b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8d21328098b, replyNumber=0, likeNumber=77, createdTime=2018-04-06, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8d21328098b, moduleTitle=临床肝胆病杂志：酒精性肝纤维化的血清标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8d21328098b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704068, encodeId=5d161e0406855, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=高敏血清标志物检测助力甲状腺癌疾病管理, objectType=article, longId=122692, objectId=cd09122692d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd09122692d7, replyNumber=0, likeNumber=108, createdTime=2018-07-13, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd09122692d7, moduleTitle=高敏血清标志物检测助力甲状腺癌疾病管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd09122692d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704069, encodeId=cb831e040697c, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=甲状腺癌血清标志物临床应用专家共识（2017 版）, objectType=article, longId=132147, objectId=367e13214e72, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=367e13214e72, replyNumber=0, likeNumber=43, createdTime=2018-05-18, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=367e13214e72, moduleTitle=甲状腺癌血清标志物临床应用专家共识（2017 版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=367e13214e72)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704067, encodeId=84b51e04067bf, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=首部《甲状腺癌血清标志物临床应用专家共识》发布, objectType=article, longId=122670, objectId=86791226e014, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86791226e014, replyNumber=0, likeNumber=87, createdTime=2018-04-27, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86791226e014, moduleTitle=首部《甲状腺癌血清标志物临床应用专家共识》发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86791226e014)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704065, encodeId=c6de1e04065d1, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=SCI REP：与慢性丙型肝炎患者肝细胞癌风险相关的临床疗效和治疗后血清标志物, objectType=article, longId=102502, objectId=eb85102502b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb85102502b4, replyNumber=0, likeNumber=90, createdTime=2017-09-28, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb85102502b4, moduleTitle=SCI REP：与慢性丙型肝炎患者肝细胞癌风险相关的临床疗效和治疗后血清标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb85102502b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704062, encodeId=579d1e040629a, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=现血清标志物，能预测个体对免疫疗法的反应！, objectType=article, longId=85360, objectId=8e588536063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e588536063, replyNumber=0, likeNumber=116, createdTime=2017-04-22, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e588536063, moduleTitle=现血清标志物，能预测个体对免疫疗法的反应！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e588536063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704066, encodeId=e01c1e04066cb, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=SCI REP：维生素D补充改善了CHC患者肝纤维化发生相关的血清标志物！, objectType=article, longId=110458, objectId=978411045885, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=978411045885, replyNumber=0, likeNumber=74, createdTime=2018-08-07, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=978411045885, moduleTitle=SCI REP：维生素D补充改善了CHC患者肝纤维化发生相关的血清标志物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=978411045885)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704064, encodeId=f94b1e0406481, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=PLos One：预测乙肝患者发生肝纤维化的新型血清标志物！, objectType=article, longId=98304, objectId=bb41983049e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb41983049e, replyNumber=0, likeNumber=82, createdTime=2018-02-24, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb41983049e, moduleTitle=PLos One：预测乙肝患者发生肝纤维化的新型血清标志物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb41983049e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704063, encodeId=06c81e0406388, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=发现血清标志物，能预测个体对免疫疗法的反应！, objectType=article, longId=85782, objectId=87d285e82d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87d285e82d9, replyNumber=0, likeNumber=57, createdTime=2017-11-23, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87d285e82d9, moduleTitle=发现血清标志物，能预测个体对免疫疗法的反应！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87d285e82d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704061, encodeId=4bc81e0406172, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=Allergy Asthma Clin Immunol：Ang-2或是哮喘严重度的血清标志物, objectType=article, longId=66315, objectId=1fe766315ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fe766315ed, replyNumber=0, likeNumber=60, createdTime=2017-03-07, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fe766315ed, moduleTitle=Allergy Asthma Clin Immunol：Ang-2或是哮喘严重度的血清标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fe766315ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704058, encodeId=c7221e0405824, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=Molecular & cellular proteomics：我国科研人员新发现7项胃癌血清标志物, objectType=article, longId=60355, objectId=669d60355b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=669d60355b9, replyNumber=0, likeNumber=83, createdTime=2015-12-09, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=669d60355b9, moduleTitle=Molecular & cellular proteomics：我国科研人员新发现7项胃癌血清标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=669d60355b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1704060, encodeId=71421e04060a2, content=<a href='/topic/show?id=f407894051e' target=_blank style='color:#2F92EE;'>#血清标志物#</a>, objectTitle=周彩存教授：血清标志物用于肺癌筛查, objectType=article, longId=63731, objectId=a95563e3186, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a95563e3186, replyNumber=0, likeNumber=67, createdTime=2016-07-16, rootId=0, userName=jichang, userId=de7930650164, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a95563e3186, moduleTitle=周彩存教授：血清标志物用于肺癌筛查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a95563e3186)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

血清标志物

2020-05-29

jichang (审核中...)

前往app查看评论内容

#血清标志物#

Liver Cancer：卡博替尼（Cabozantinib）对比安慰剂治疗晚期肝细胞癌患者的基于血清标志物的预后分析：3期临床研究CELESTIAL

2022-06-26

jichang (审核中...)

前往app查看评论内容

#血清标志物#

Clin Trans Gastroenterology：β6 -整合素可作为胰腺腺癌诊断和预后的血清标志物

2021-12-21

jichang (审核中...)

前往app查看评论内容

#血清标志物#

2020脓毒症预防和阻断专家共识告诉你：这些血清标志物很重要！

2020-11-03

jichang (审核中...)

前往app查看评论内容

#血清标志物#

Gastric Cancer：血清标志物在胃癌及癌前病变中的作用

2020-07-01

jichang (审核中...)

前往app查看评论内容

#血清标志物#

PLOS ONE：肺癌患者的氧化应激与脂质代谢的血清标志物改变有关

2019-11-07

jichang (审核中...)

前往app查看评论内容

#血清标志物#

Diabetes Care：氧化应激血清标志物与2型糖尿病患者的主要心血管事件、癌症发病率和全因死亡率的关联

2020-04-01

jichang (审核中...)

前往app查看评论内容

#血清标志物#

对话检验与临床：科学应用，合理解读 ——血清标志物优化甲状腺疾病临床诊疗

2019-09-11

jichang (审核中...)

前往app查看评论内容

#血清标志物#

J Clin Periodontol：唾液和血清标志物在牙周炎和冠心病中的应用

2019-01-05

jichang (审核中...)

前往app查看评论内容

#血清标志物#

临床肝胆病杂志：酒精性肝纤维化的血清标志物

2018-04-06

jichang (审核中...)

前往app查看评论内容

#血清标志物#

高敏血清标志物检测助力甲状腺癌疾病管理

2018-07-13

jichang (审核中...)

前往app查看评论内容

#血清标志物#

甲状腺癌血清标志物临床应用专家共识（2017 版）

2018-05-18

jichang (审核中...)

前往app查看评论内容

#血清标志物#

首部《甲状腺癌血清标志物临床应用专家共识》发布

2018-04-27

jichang (审核中...)

前往app查看评论内容

#血清标志物#

SCI REP：与慢性丙型肝炎患者肝细胞癌风险相关的临床疗效和治疗后血清标志物

2017-09-28

jichang (审核中...)

前往app查看评论内容

#血清标志物#

现血清标志物，能预测个体对免疫疗法的反应！

2017-04-22

jichang (审核中...)

前往app查看评论内容

#血清标志物#

SCI REP：维生素D补充改善了CHC患者肝纤维化发生相关的血清标志物！

2018-08-07

jichang (审核中...)

前往app查看评论内容

#血清标志物#

PLos One：预测乙肝患者发生肝纤维化的新型血清标志物！

2018-02-24

jichang (审核中...)

前往app查看评论内容

#血清标志物#

发现血清标志物，能预测个体对免疫疗法的反应！

2017-11-23

jichang (审核中...)

前往app查看评论内容

#血清标志物#

Allergy Asthma Clin Immunol：Ang-2或是哮喘严重度的血清标志物

2017-03-07

jichang (审核中...)

前往app查看评论内容

#血清标志物#

Molecular & cellular proteomics：我国科研人员新发现7项胃癌血清标志物

2015-12-09

jichang (审核中...)

前往app查看评论内容

#血清标志物#

周彩存教授：血清标志物用于肺癌筛查

2016-07-16

科室
- - 订阅+
  - 更多科室
工具
服务